share_log

信达生物(01801.HK)将于8月25日举行董事会会议以审批中期业绩

INNOVENT BIO (01801.HK) will hold a board meeting on August 25th to approve interim results

Gelonghui Finance ·  Aug 9, 2022 18:45

INNOVENT BIO (01801.HK) announced that the company will hold a board meeting on August 25, 2022 to consider and approve the interim results and announcements of the company and its subsidiaries for the six months ended June 30, 2022.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment